Contact: Christen Carter
chrcarter@georgiahealth.edu
706-721-5733
Georgia Health Sciences University

Samir N. Khleif, Georgia Health Sciences University

Caption: Select patients with advanced prostate cancer may benefit from a Georgia Health Sciences University Cancer Center clinical trial, led by GHSU Cancer Center Director Samir N. Khleif, that looks to improve survival rates of the FDA-approved prostate cancer drug Provenge.

Credit: Phil Jones, Georgia Health Sciences University Photographer

Usage Restrictions: None

Related news release: Clinical trial at GHSU Cancer Center targets advanced prostate cancer